πŸ‡ΊπŸ‡Έ FDA
Patent

US 11884672

Modulators of alpha-1 antitrypsin

granted A61KA61K31/4162A61K9/1635

Quick answer

US patent 11884672 (Modulators of alpha-1 antitrypsin) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4162, A61K9/1635, A61K9/1652, A61P